Abstract:Our previous studies demonstrated that the natural compound emodin blocks the tumor-promoting feedforward interactions between cancer cells and macrophages, and thus ameliorates the immunosuppressive state of the tumor microenvironment. Since tumor-associated macrophages (TAMs) also affect epithelial mesenchymal-transition (EMT) and cancer stem cell (CSC) formation, here we aimed to test if emodin as a neoadjuvant therapy halts breast cancer metastasis by attenuating TAM-induced EMT and CSC formation of breast cancer cells.Methods: Bioinformatical analysis was performed to examine the correlation between macrophage abundance and EMT/CSC markers in human breast tumors. Cell culture and co-culture studies were performed to test if emodin suppresses TGF-beta 1 or macrophage-induced EMT and CSC formation of breast cancer cells, and if it inhibits breast cancer cell migration and invasion. Using mouse models, we tested if short-term administration of emodin before surgical removal of breast tumors halts breast cancer post-surgery metastatic recurrence in the lungs. The effects of emodin on TGF-beta 1 signaling pathways in breast cancer cells were examined by western blots and immunofluorescent imaging.Results: Macrophage abundance positively correlates with EMT and CSC markers in human breast tumors. Emodin suppressed TGF-beta 1 production in breast cancer cells and macrophages and attenuated TGF-beta 1 or macrophage-induced EMT and CSC formation of breast cancer cells. Short-term administration of emodin before surgery halted breast cancer post-surgery metastatic recurrence in the lungs by reducing tumor-promoting macrophages and suppressing EMT and CSC formation in the primary tumors. Mechanistic studies revealed that emodin inhibited both canonical and noncanonical TGF-beta 1 signaling pathways in breast cancer cells and suppressed transcription factors key to EMT and CSC.Conclusion: Natural compound emodin suppresses EMT and CSC formation of breast cancer cells by blocking TGF-beta 1-mediated crosstalk between TAMs and breast cancer cells. Our study provides evidence suggesting that emodin harbors the potential for clinical development as a new effective and safe agent to halt metastatic recurrence of breast cancer.

Macrophage Targeting Contributes to the Inhibitory Effects of Embelin on Colitis-Associated Cancer.

Embelin impairs the accumulation and activation of MDSCs in colitis-associated tumorigenesis.

Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.

Β-Elemene Inhibits Tumor-Promoting Effect of M2 Macrophages in Lung Cancer.

Modulation of tumor-associated macrophages in colitis-associated colorectal cancer.

Fungal‐induced Glycolysis in Macrophages Promotes Colon Cancer by Enhancing Innate Lymphoid Cell Secretion of IL‐22

Emodin suppresses hepatocellular carcinoma growth by regulating macrophage polarization via microRNA-26a/transforming growth factor beta 1/protein kinase B

Aqueous Extract of Cimicifuga dahurica Reprogramming Macrophage Polarization by Activating TLR4-NF-κB Signaling Pathway

Emodin Reduces Breast Cancer Lung Metastasis By Suppressing Macrophage-Induced Breast Cancer Cell Epithelial-Mesenchymal Transition And Cancer Stem Cell Formation

Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells.

Peroxisome Proliferator-Activated Receptor-Gamma Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis

Curcumin inhibits malignant behavior of colorectal cancer cells by regulating M2 polarization of tumor-associated macrophages and metastasis associated in colon cancer 1 (MACC1) expression

Embelin Inhibits Pancreatic Cancer Progression by Directly Inducing Cancer Cell Apoptosis and Indirectly Restricting IL-6 Associated Inflammatory and Immune Suppressive Cells11these Authors Contributed Equally to This Work.

Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome

Macelignan Prevents Colorectal Cancer Metastasis by Inhibiting M2 Macrophage Polarization

[Effect of Macrophages on Ulcerative Colitis-Associated Carcinogenesis].

Effect Of Tumor Cell-Derived Debris And Igg On Metastasis Of Pancreatic Cancer And Inflammation Through Tumor-Associated Macrophages.

A Comprehensive Review of Phytochemicals Targeting Macrophages for the Regulation of Colorectal Cancer Progression

T2001 Inhibitory Effect of Embelin on Colon Carcinogenesis is Peroxisome Proliferator-Activated Receptor Γ (Pparγ)-Dependent

CircMERTK modulates the suppressive capacity of tumor-associated macrophage via targeting IL-10 in colorectal cancer